Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Lung Non-Small Cell Cancer AJCC v7”

347 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 347 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06540950
What this trial is testing

Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

Who this might be right for
Vinorelbine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 47
Testing effectiveness (Phase 2)UnknownNCT04111913
What this trial is testing

Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Unresectable Stage III Non-small Cell Lung Cancer
Nanfang Hospital, Southern Medical University 100
Large-scale testing (Phase 3)Study completedNCT00002823
What this trial is testing

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 3,300
Testing effectiveness (Phase 2)Looking for participantsNCT03694236
What this trial is testing

Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC

Who this might be right for
Potentially Resectable Stage II/IIIa NSCLC
Yonsei University 39
Early research (Phase 1)Ended earlyNCT01124812
What this trial is testing

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Philogen S.p.A. 3
Testing effectiveness (Phase 2)Study completedNCT03822351
What this trial is testing

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

Who this might be right for
Stage III Non-small Cell Lung CancerUnresectable
MedImmune LLC 189
Testing effectiveness (Phase 2)Active Not RecruitingNCT07632365
What this trial is testing

Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung CancerUnresectable Stage III NSCLC
Shanghai Chest Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00618917
What this trial is testing

MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
EsophagealToxicity
Joel Greenberger 18
Large-scale testing (Phase 3)WithdrawnNCT00055887
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Spectrum Pharmaceuticals, Inc
Early research (Phase 1)Not Yet RecruitingNCT07523464
What this trial is testing

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

Who this might be right for
Locally-Advanced Non-Small Cell Lung CancerRadiotherapy
Anhui Provincial Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00103051
What this trial is testing

Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Study completedNCT00003002
What this trial is testing

HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer

Who this might be right for
Breast CancerLung CancerOvarian Cancer
University of Washington 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561983
What this trial is testing

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

Who this might be right for
Unresectable Stage III Non-small Cell Lung CancerTislelizumabChemotherapy+2 more
Sichuan Cancer Hospital and Research Institute 39
Not applicableStudy completedNCT04836975
What this trial is testing

Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:

Who this might be right for
Lung Cancer
AstraZeneca 45
Testing effectiveness (Phase 2)UnknownNCT05414630
What this trial is testing

Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III
Anhui Provincial Cancer Hospital 30
Early research (Phase 1)Study completedNCT02520778
What this trial is testing

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Non-Small Cell Cancer AJCC v7+3 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)UnknownNCT00274898
What this trial is testing

Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 80
Testing effectiveness (Phase 2)Looking for participantsNCT05011487
What this trial is testing

Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01266512
What this trial is testing

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

Who this might be right for
Lung Neoplasms
Sanofi 34
Not applicableStudy completedNCT03725475
What this trial is testing

Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
AstraZeneca 3,111
Load More Results